Autor der Publikation

Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing.

, , , , , , , , und . (2022)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation., , , , , , , , , und 5 andere Autor(en). (2022)Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function, , , , , , , , , und 9 andere Autor(en). (2022)Reprogramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Exacerbation of Chronic Obstructive Pulmonary Disease, , , , , , , , , und 6 andere Autor(en). Cells, 11 (15): 2283 (Juli 2022)Studying long-term health and quality of life after infection with SARS-CoV-2: design and rationale of the population-based NAPKON POP study, , , , , , , , , und 31 andere Autor(en). (2021)The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics, , , , , , , , , und 65 andere Autor(en). Eur J Epidemiol, 37 (8): 849-870 (2022)Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population, , , , , , , , , und 9 andere Autor(en). Hum Vaccin Immunother, 0 (0): 1-10 (2017)PMID: 28394705.Defining the role of common variation in the genomic and biological architecture of adult human height, , , , , , , , , und 794 andere Autor(en). Nat. Genet., 46 (11): 1173--1186 (November 2014)Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies., , , , , , , , , und 4 andere Autor(en). (2022)Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP), , , , , , , , , und 31 andere Autor(en). Infection, 49 (6): 1277-1287 (2021)Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease, , , , , , , , , und 19 andere Autor(en). PLOS ONE, 16 (8): 1-24 (August 2021)